These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3516541)

  • 1. [The control of bronchial secretions in chronic hypersecretory bronchopneumopathies: the role of letosteine].
    Morandini G; Finiguerra M; Fraticelli G; Ferraris F; Gallone F
    Clin Ter; 1986 Feb; 116(3):179-93. PubMed ID: 3516541
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drugs active on mucus in the primary treatment of chronic bronchitis. Controlled study of the activity of letosteine].
    Cremonini C; Spada E; Cellini F; Cioni R; Giovannini M; Perri G; Priolo U; Fraticelli G; Gusmitta A
    Clin Ter; 1986 Jan; 116(2):121-9. PubMed ID: 3516537
    [No Abstract]   [Full Text] [Related]  

  • 3. [A new contribution to the treatment of chronic bronchopneumopathies: letosteine].
    Macquet V; Ficheroulle X; Ta Van P; Peltier M
    Lille Med; 1979 Nov; 24(9):735-8. PubMed ID: 529981
    [No Abstract]   [Full Text] [Related]  

  • 4. [Letosteine in chronic obstructive bronchopneumopathy].
    Meroni P; Palmieri G; De Bartolo G; Barcellini W; Albrici A; Froldi M
    Clin Ter; 1983 Apr; 105(2):109-18. PubMed ID: 6345052
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical evaluation of letosteine activity in the treatment of acute febrile bronchitis in children. Double-blind controlled study versus placebo].
    Nespoli L; Monafo V; Bonetti F; Terracciano L; Savio G
    Minerva Pediatr; 1989 Oct; 41(10):515-20. PubMed ID: 2693929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative clinical evaluation of two mucolytic agents: S-carboxy-methyl-cysteine and letosteine (author's transl)].
    Blaive B; Lapalus P; Lemoigne F
    Sem Hop; 1978 Oct 8-15; 54(29-32):983-6. PubMed ID: 216094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No demonstrable effect of sobrerol as an expectorant in patients with stable chronic bronchial diseases.
    Medici TC; Shang H; Grosgurin P; Berg P; Achermann R; Wehrli R
    Bull Eur Physiopathol Respir; 1985; 21(6):477-83. PubMed ID: 3907738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rheological profile of nesosteine: a new mucoactive agent.
    Braga PC; Beghi G; Castelli C; Grasselli G; Ornaghi A; Rampoldi C; Zheng Y; Allegra L
    Int J Clin Pharmacol Res; 1989; 9(1):77-83. PubMed ID: 2707929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of letosteine on muco-ciliary transport in patients with chronic bronchopathy].
    Olivieri D; Del Donno M; Schettini A
    Arch Monaldi; 1983; 38(3):105-12. PubMed ID: 6675560
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drug therapy of bronchosecretolytic disorders].
    Schmidt OP
    Med Klin; 1977 Feb; 72(5):145-60. PubMed ID: 321928
    [No Abstract]   [Full Text] [Related]  

  • 11. [Contribution to the treatment of serous or purulent bronchial hypersecretion in acute and chronic bronchopneumopathies].
    Baracco F; Repetto E; Giordano L
    Minerva Med; 1969 Sep; 60(75):3509-13. PubMed ID: 5344811
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic efficacy and general tolerability of 4-carbomethoxythiazolidine chlorohydrate in adult patients with hypersecretory bronchopulmonary diseases].
    Campisi U; Sciutto L; Patti S
    Boll Chim Farm; 1990; 129(10-11):56S-59S. PubMed ID: 2102703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucoid impaction of the bronchi.
    Urschel HC; Paulson DL; Shaw RR
    Ann Thorac Surg; 1966 Jan; 2(1):1-16. PubMed ID: 5924799
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of serous and puruloid bronchial hypersecretions in acute and chronic bronchopneumopathies: our experience with a new mucolytic drug].
    Fossati C
    Clin Ter; 1975 Jul; 74(1):63-82. PubMed ID: 770054
    [No Abstract]   [Full Text] [Related]  

  • 15. [Correction of mucociliary insufficiency: present-day modalities and perspectives].
    Ter Arkh; 2006; 78(3):74-84. PubMed ID: 17019964
    [No Abstract]   [Full Text] [Related]  

  • 16. [Controlled clinical study of the therapeutic activity of arginine thiazolidine carboxylate in patients with chronic toxic and postinfective hepatopathies].
    Salsano F; Ciancarelli MP
    Minerva Dietol Gastroenterol; 1979; 25(4):391-8. PubMed ID: 400006
    [No Abstract]   [Full Text] [Related]  

  • 17. Review on sobrerol as a muco-modifying drug: experimental data and clinical findings in hypersecretory bronchopulmonary diseases.
    Braga PC; Allegra L; Bossi R; Scuri R; Castiglioni CL; Romandini S
    Int J Clin Pharmacol Res; 1987; 7(5):381-400. PubMed ID: 3312046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the activity of the carbocysteine-sobrerol combination on mucus spinnability.
    Distefano SM; Palermo F; Crimi N; Mistretta A; Pamparana F; Messa A
    Int J Clin Pharmacol Res; 1988; 8(1):31-5. PubMed ID: 3284830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bisolvon in pneumological practice].
    Ollagnier C; Vallon MC
    Lyon Med; 1969 Dec; 222(46):1233-5. PubMed ID: 4905093
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of seaprose on the rheology of bronchial mucus in patients with chronic bronchitis. A double-blind study vs placebo.
    Braga PC; Moretti M; Piacenza A; Montoli CC; Guffanti EE
    Int J Clin Pharmacol Res; 1993; 13(3):179-85. PubMed ID: 8225701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.